Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models

<p>Related to Figure 2 - SMS-CTR</p>

Gardado en:

Detalles Bibliográficos
Autor Principal:	Katie E. Hebron (15046889) (author)
Outros autores:	Xiaolin Wan (15046892) (author), Jacob S. Roth (15046895) (author), David J. Liewehr (15046898) (author), Nancy E. Sealover (15046901) (author), William J.E. Frye (15046904) (author), Angela Kim (15046907) (author), Stacey Stauffer (15046910) (author), Olivia L. Perkins (15046913) (author), Wenyue Sun (15046916) (author), Kristine A. Isanogle (15046919) (author), Christina M. Robinson (15046922) (author), Amy James (15046925) (author), Parirokh Awasthi (15046928) (author), Priya Shankarappa (15046931) (author), Xiaoling Luo (15046934) (author), Haiyan Lei (14963261) (author), Donna Butcher (15046937) (author), Roberta Smith (15046940) (author), Elijah F. Edmondson (14950075) (author), Jin-Qiu Chen (15046943) (author), Noemi Kedei (15046946) (author), Cody J. Peer (14946853) (author), Jack F. Shern (14938001) (author), W. Douglas Figg (15046949) (author), Lu Chen (15046952) (author), Matthew D. Hall (14938004) (author), Simone Difilippantonio (15046955) (author), Frederic G. Barr (15046958) (author), Robert L. Kortum (15046961) (author), Robert W. Robey (15046964) (author), Angelina V. Vaseva (14949310) (author), Javed Khan (15046967) (author), Marielle E. Yohe (15046970) (author)
Publicado:	2025
Subjects:	Cancer Therapeutic Research and Development Methods and Technology Drug Targets Cell surface receptor drug targets Protein kinase & phosphatase drug targets Pediatric Cancers Preclinical Models Animal models of cancer Translational Research
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

_version_	1849927634202394624
author	Katie E. Hebron (15046889)
author2	Xiaolin Wan (15046892) Jacob S. Roth (15046895) David J. Liewehr (15046898) Nancy E. Sealover (15046901) William J.E. Frye (15046904) Angela Kim (15046907) Stacey Stauffer (15046910) Olivia L. Perkins (15046913) Wenyue Sun (15046916) Kristine A. Isanogle (15046919) Christina M. Robinson (15046922) Amy James (15046925) Parirokh Awasthi (15046928) Priya Shankarappa (15046931) Xiaoling Luo (15046934) Haiyan Lei (14963261) Donna Butcher (15046937) Roberta Smith (15046940) Elijah F. Edmondson (14950075) Jin-Qiu Chen (15046943) Noemi Kedei (15046946) Cody J. Peer (14946853) Jack F. Shern (14938001) W. Douglas Figg (15046949) Lu Chen (15046952) Matthew D. Hall (14938004) Simone Difilippantonio (15046955) Frederic G. Barr (15046958) Robert L. Kortum (15046961) Robert W. Robey (15046964) Angelina V. Vaseva (14949310) Javed Khan (15046967) Marielle E. Yohe (15046970)
author2_role	author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author
author_facet	Katie E. Hebron (15046889) Xiaolin Wan (15046892) Jacob S. Roth (15046895) David J. Liewehr (15046898) Nancy E. Sealover (15046901) William J.E. Frye (15046904) Angela Kim (15046907) Stacey Stauffer (15046910) Olivia L. Perkins (15046913) Wenyue Sun (15046916) Kristine A. Isanogle (15046919) Christina M. Robinson (15046922) Amy James (15046925) Parirokh Awasthi (15046928) Priya Shankarappa (15046931) Xiaoling Luo (15046934) Haiyan Lei (14963261) Donna Butcher (15046937) Roberta Smith (15046940) Elijah F. Edmondson (14950075) Jin-Qiu Chen (15046943) Noemi Kedei (15046946) Cody J. Peer (14946853) Jack F. Shern (14938001) W. Douglas Figg (15046949) Lu Chen (15046952) Matthew D. Hall (14938004) Simone Difilippantonio (15046955) Frederic G. Barr (15046958) Robert L. Kortum (15046961) Robert W. Robey (15046964) Angelina V. Vaseva (14949310) Javed Khan (15046967) Marielle E. Yohe (15046970)
author_role	author
dc.creator.none.fl_str_mv	Katie E. Hebron (15046889) Xiaolin Wan (15046892) Jacob S. Roth (15046895) David J. Liewehr (15046898) Nancy E. Sealover (15046901) William J.E. Frye (15046904) Angela Kim (15046907) Stacey Stauffer (15046910) Olivia L. Perkins (15046913) Wenyue Sun (15046916) Kristine A. Isanogle (15046919) Christina M. Robinson (15046922) Amy James (15046925) Parirokh Awasthi (15046928) Priya Shankarappa (15046931) Xiaoling Luo (15046934) Haiyan Lei (14963261) Donna Butcher (15046937) Roberta Smith (15046940) Elijah F. Edmondson (14950075) Jin-Qiu Chen (15046943) Noemi Kedei (15046946) Cody J. Peer (14946853) Jack F. Shern (14938001) W. Douglas Figg (15046949) Lu Chen (15046952) Matthew D. Hall (14938004) Simone Difilippantonio (15046955) Frederic G. Barr (15046958) Robert L. Kortum (15046961) Robert W. Robey (15046964) Angelina V. Vaseva (14949310) Javed Khan (15046967) Marielle E. Yohe (15046970)
dc.date.none.fl_str_mv	2025-11-25T12:44:36Z
dc.identifier.none.fl_str_mv	10.1158/1078-0432.30706067
dc.relation.none.fl_str_mv	https://figshare.com/articles/dataset/Supplementary_Data_File_S6_from_The_Combination_of_Trametinib_and_Ganitumab_is_Effective_in_RAS-Mutated_PAX-Fusion_Negative_Rhabdomyosarcoma_Models/30706067
dc.rights.none.fl_str_mv	CC BY info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv	Cancer Therapeutic Research and Development Methods and Technology Drug Targets Cell surface receptor drug targets Protein kinase & phosphatase drug targets Pediatric Cancers Preclinical Models Animal models of cancer Translational Research
dc.title.none.fl_str_mv	Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
dc.type.none.fl_str_mv	Dataset info:eu-repo/semantics/publishedVersion dataset
description	<p>Related to Figure 2 - SMS-CTR</p>
eu_rights_str_mv	openAccess
id	Manara_6554b51951baf1699870f2260b290729
identifier_str_mv	10.1158/1078-0432.30706067
network_acronym_str	Manara
network_name_str	ManaraRepo
oai_identifier_str	oai:figshare.com:article/30706067
publishDate	2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv	CC BY
spelling	Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma ModelsKatie E. Hebron (15046889)Xiaolin Wan (15046892)Jacob S. Roth (15046895)David J. Liewehr (15046898)Nancy E. Sealover (15046901)William J.E. Frye (15046904)Angela Kim (15046907)Stacey Stauffer (15046910)Olivia L. Perkins (15046913)Wenyue Sun (15046916)Kristine A. Isanogle (15046919)Christina M. Robinson (15046922)Amy James (15046925)Parirokh Awasthi (15046928)Priya Shankarappa (15046931)Xiaoling Luo (15046934)Haiyan Lei (14963261)Donna Butcher (15046937)Roberta Smith (15046940)Elijah F. Edmondson (14950075)Jin-Qiu Chen (15046943)Noemi Kedei (15046946)Cody J. Peer (14946853)Jack F. Shern (14938001)W. Douglas Figg (15046949)Lu Chen (15046952)Matthew D. Hall (14938004)Simone Difilippantonio (15046955)Frederic G. Barr (15046958)Robert L. Kortum (15046961)Robert W. Robey (15046964)Angelina V. Vaseva (14949310)Javed Khan (15046967)Marielle E. Yohe (15046970)CancerTherapeutic Research and DevelopmentMethods and TechnologyDrug TargetsCell surface receptor drug targetsProtein kinase & phosphatase drug targetsPediatric CancersPreclinical ModelsAnimal models of cancerTranslational Research<p>Related to Figure 2 - SMS-CTR</p>2025-11-25T12:44:36ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30706067https://figshare.com/articles/dataset/Supplementary_Data_File_S6_from_The_Combination_of_Trametinib_and_Ganitumab_is_Effective_in_RAS-Mutated_PAX-Fusion_Negative_Rhabdomyosarcoma_Models/30706067CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307060672025-11-25T12:44:36Z
spellingShingle	Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models Katie E. Hebron (15046889) Cancer Therapeutic Research and Development Methods and Technology Drug Targets Cell surface receptor drug targets Protein kinase & phosphatase drug targets Pediatric Cancers Preclinical Models Animal models of cancer Translational Research
status_str	publishedVersion
title	Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
title_full	Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
title_fullStr	Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
title_full_unstemmed	Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
title_short	Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
title_sort	Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
topic	Cancer Therapeutic Research and Development Methods and Technology Drug Targets Cell surface receptor drug targets Protein kinase & phosphatase drug targets Pediatric Cancers Preclinical Models Animal models of cancer Translational Research

Supplementary Data File S6 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models

Títulos similares